BiOraliX’ proprietary formulation technology provides a new way to orally
deliver biopharmaceutical therapies patient friendly and with superior
bioavailability. For patients, self-medication is now within reach
for the most complex biologics treatments, especially for chronic
diseases such as rheumatoid arthritis, allergy and asthma.
BiOraliX’ technology enables protein to be captured into nanoparticles
to provide a stable environment. Nanoparticle composition, shape and
dimensions can be optimized specific for the protein towards optimal
release and absorption.
The benefits of an oral delivery versus subcutaneous
or intravenous are vast:
All these benefits open up many new opportunities to biopharmaceutical companies:
Feel free to contact us to learn more.